Argenx
ARGX
#485
Rank
A$74.03 B
Marketcap
A$1,196
Share price
-1.38%
Change (1 day)
10.50%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report